反应详情

A solution of N-{5-(bromoacetyl)-2-[(phenylmethyl)oxy]phenyl}-N-(phenylmethyl) methanesulfonamide (570 mg) in THF (15 ml) was treated with N,N-diisopropylethylamine (0.41 ml) and (S)-(+)-2-phenylglycinol (191.8 mg). The mixture was stirred at room temperature for 5 h. The solvent was removed in vacuo and the resulting solid was suspended in dry MeOH (15 ml). The resulting suspension was cooled to 0°, treated with calcium carbonate (359 mg) and stirred for 0.5 h. The reaction mixture was treated with NaBH4 (88.8 mg), portionwise at 0° and was then allowed to warm to room temperature and stirred for 64 h. The mixture was concentrated in vacuo and the residue was partitioned between EtOAc and water. The organic phase was dried (MgSO4) and concentrated in vacuo. The mixture was purified by column chromatography (SPE, gradient 0 to 15% [MeOH-ammonia (10:1)] in DCM) to afford the title compound (360 mg).

1. customThe solvent was removed in vacuo
2. temperatureThe resulting suspension was cooled to 0°
3. additiontreated with calcium carbonate (359 mg)
4. stirringstirred for 0.5 h
5. additionThe reaction mixture was treated with NaBH4 (88.8 mg), portionwise at 0°
6. temperatureto warm to room temperature
7. stirringstirred for 64 h
8. concentrationThe mixture was concentrated in vacuo
9. customthe residue was partitioned between EtOAc and water
10. dry with materialThe organic phase was dried (MgSO4)
11. concentrationconcentrated in vacuo
12. customThe mixture was purified by column chromatography (SPE, gradient 0 to 15% [MeOH-ammonia (10:1)] in DCM)